Skip to content

Brexit – deal or no deal for labelling?

With the end result of Brexit fast approaching, labelling supplier Kallik looks at the implications Brexit could place on labelling and compliance in the pharmaceutical sector.

By Kallik
Brexit – deal or no deal for labelling?
Published: | 4 min read

With the end result of Brexit fast approaching, labelling supplier Kallik looks at the implications Brexit could place on labelling and compliance in the pharmaceutical sector.   

Brexit

The time for the UK to leave the EU is fast approaching. With March 29th 2019 the official date. The post-Brexit transition period is in fact set to run until December 31st 2020, meaning the chances are very high that the UK-EU relationship will be staying the same until then, but two years in the labelling lifecycle can pass very quickly.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information